37 results on '"Soliman, Osama"'
Search Results
2. Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis - A real-world Indian experience (The OCTACOR India Study).
- Author
-
Jose J, Mandalay A, Cholenahally MN, Khandenahally RS, Budnur SC, Parekh M, Rao RS, Seth A, Chandra P, Kapoor R, Agarwal P, Mathur A, Kumar V, Kanchanahalli SS, Mullasari AS, Subban V, Khanolkar UB, Mehrotra S, Chopra M, Jain RK, Mehta H, Gupta R, Kumar V, Raghuraman B, Shastri N, Elzomor H, Soliman O, and Gunasekaran S
- Subjects
- Humans, Female, Male, Treatment Outcome, Aged, India, Time Factors, Aged, 80 and over, Middle Aged, Risk Factors, Recovery of Function, Postoperative Complications, Retrospective Studies, Hemodynamics, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis surgery, Aortic Valve Stenosis mortality, Aortic Valve Stenosis physiopathology, Registries, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement adverse effects, Transcatheter Aortic Valve Replacement instrumentation, Transcatheter Aortic Valve Replacement mortality, Prosthesis Design, Severity of Illness Index, Aortic Valve diagnostic imaging, Aortic Valve surgery, Aortic Valve physiopathology
- Abstract
Purpose: To evaluate the safety and effectiveness of the novel, next-generation Myval Octacor - Transcatheter Heart Valve (THV) in patients with severe, symptomatic, native aortic stenosis (AS)., Methods: This multicenter, real-world observational registry included 123 patients with severe symptomatic AS, across 16 Indian centers who underwent treatment with the novel Myval Octacor THV. Study endpoints included all-cause mortality, all stroke, acute kidney injury (AKI), major vascular complications, moderate or severe paravalvular leakage (PVL) and new permanent pacemaker implantation (PPI) until 30 days follow-up., Results: Of the 123 patients (average age 70.07 ± 8.33 years), 37.4 % (n = 46) were female and 39.84 % presented with bicuspid valves. The technical success rate of the procedure was 100 % and the device success rate at 30 days was 98.4 %. At 30 days (n = 123) after the procedure, the overall mortality was 1.6 %. AKI occurred in 1.6 % of patients and there was no incidence of stroke, bleeding (types 3 and 4), and major vascular complications. In an analysis of 31 patients whose echocardiographic parameters were available across all timepoints, there were significant improvements in the mean pressure gradient (54.31 ± 18.19 mmHg vs. 10.42 ± 4.24 mmHg; p < 0.0001) and effective orifice area (0.66 ± 0.21 cm
2 vs. 1.80 ± 0.44 cm2 ; p < 0.0001) from baseline to the 30-day follow-up. None of the patients experienced severe PVL, while moderate PVL was observed in two patients (1.6 %)., Conclusions: Early outcomes of the next-generation, novel Myval Octacor THV proved its safety and effectiveness in the treatment of severe AS., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Sengottuvelu Gunasekaran reports a relationship with Meril Life Sciences Pvt. Ltd. that includes: consulting or advisory. John Jose, Ashok Seth, Ravinder S. Rao & Haresh Mehta reports a relationship with Meril Life Sciences Pvt. Ltd. that includes: consulting or advisory. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF
3. Chronic haemodynamic performance of a biorestorative transcatheter heart valve in an ovine model.
- Author
-
Serruys PW, Kawashima H, Chang CC, Modolo R, Wang R, de Winter RJ, Van Hauwermeiren H, El-Kurdi M, van den Bergh W, Cox M, Onuma Y, Flameng W, and Soliman O
- Subjects
- Animals, Aortography, Catheters, Echocardiography, Sheep, Aortic Valve diagnostic imaging, Aortic Valve surgery, Hemodynamics
- Abstract
Background: The Xeltis biorestorative transcatheter heart valve (BTHV) leaflets are made from an electrospun bioabsorbable supramolecular polycarbonate-urethane and are mounted on a self-expanding nitinol frame. The acute haemodynamic performance of this BTHV was favourable., Aims: We sought to demonstrate the preclinical feasibility of a novel BTHV by evaluating the haemodynamic performances of five pilot valve designs up to 12 months in a chronic ovine model., Methods: Five design iterations (A, B, B', C, and D) of the BTHV were transapically implanted in 46 sheep; chronic data were available in 39 animals. Assessments were performed at implantation, 3, 6, and 12 months including quantitative aortography, echocardiography, and histology., Results: At 12 months, greater than or equal to moderate AR on echocardiography was seen in 0%, 100%, 33.3%, 100%, and 0% in the iterations A, B, B', C, and D, respectively. Furthermore, transprosthetic mean gradients on echocardiography were 10.0±2.8 mmHg, 19.0±1.0 mmHg, 8.0±1.7 mmHg, 26.8±2.4 mmHg, and 11.2±4.1 mmHg, and effective orifice area was 0.7±0.3 cm2, 1.1±0.3 cm2, 1.5±1.0 cm2, 1.5±0.6 cm2, and 1.0±0.4 cm2 in the iterations A, B, B', C, and D, respectively. On pathological evaluation, the iteration D demonstrated generally intact leaflets and advanced tissue coverage, while different degrees of structural deterioration were observed in the other design iterations., Conclusions: Several leaflet material iterations were compared for the potential to demonstrate endogenous tissue restoration in an aortic valve in vivo. The most promising iteration showed intact leaflets and acceptable haemodynamic performance at 12 months, illustrating the potential of the BTHV.
- Published
- 2021
- Full Text
- View/download PDF
4. Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study.
- Author
-
Blackman DJ, Van Gils L, Bleiziffer S, Gerckens U, Petronio AS, Abdel-Wahab M, Werner N, Khogali SS, Wenaweser P, Wöhrle J, Soliman O, Laborde JC, Allocco DJ, Meredith IT, Falk V, and Van Mieghem NM
- Subjects
- Aged, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis etiology, Aortic Valve Stenosis physiopathology, Bicuspid Aortic Valve Disease, Europe, Female, Heart Valve Diseases diagnostic imaging, Heart Valve Diseases physiopathology, Heart Valve Prosthesis Implantation adverse effects, Hemodynamics, Humans, Latin America, Male, New Zealand, Product Surveillance, Postmarketing, Prospective Studies, Prosthesis Design, Recovery of Function, Registries, Time Factors, Treatment Outcome, Aortic Valve abnormalities, Aortic Valve Stenosis surgery, Heart Valve Diseases complications, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation instrumentation
- Abstract
Aims: Patients with bicuspid valves represent a challenging anatomical subgroup for transcatheter aortic valve implantation (TAVI). This analysis evaluated the clinical outcomes of the fully repositionable and retrievable Lotus Valve System in patients with bicuspid aortic valves enrolled in the RESPOND post-market registry., Methods and Results: The prospective, open-label RESPOND study enrolled 1,014 patients at 41 centers in Europe, New Zealand, and Latin America, 31 (3.1%) of whom had bicuspid aortic valves. The mean age in the bicuspid patient cohort was 76.4 years, 64.5% were male, and the baseline STS score was 6.0 ± 10.2. Procedural success was 100%, with no cases of malpositioning, valve migration, embolization, or valve-in-valve. Repositioning was attempted in 10 cases (32.3%). There was one death (3.2%) and one stroke (3.2%) at 30-day follow-up. Mean AV gradient was reduced from 48.7 ± 17.0 mmHg at baseline to 11.8 ± 5.1 mmHg at hospital discharge (P < 0.001); mean effective orifice area (EOA) was increased from 0.6 ± 0.2 cm
2 to 1.7 ± 0.4 cm2 (P < 0.001). There were no cases of moderate or severe paravalvular leak (PVL) adjudicated by the core laboratory; four subjects (13.8%) had mild PVL, 5 (17.2%) had trace PVL. The rate of pacemaker (PM) implantation for PM-naïve patients was 22.2% (6/27)., Conclusions: Data from the RESPOND registry demonstrate good clinical and echocardiographic outcomes up to 1 year postimplantation in patients with bicuspid aortic valves using the repositionable Lotus Valve., (© 2019 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.)- Published
- 2019
- Full Text
- View/download PDF
5. Feasibility study of a synchronized diastolic injection with low contrast volume for proper quantitative assessment of aortic regurgitation in porcine models.
- Author
-
Modolo R, Miyazaki Y, Chang CC, Te Lintel Hekkert M, van Sloun M, Suchecki T, Aben JP, Soliman OI, Onuma Y, Duncker DJ, van Mieghem NM, and Serruys PW
- Subjects
- Animals, Aortic Valve physiopathology, Aortic Valve Insufficiency physiopathology, Diastole, Disease Models, Animal, Electrocardiography, Feasibility Studies, Female, Heart Rate, Injections, Predictive Value of Tests, Reproducibility of Results, Sus scrofa, Time Factors, Aortic Valve diagnostic imaging, Aortic Valve Insufficiency diagnostic imaging, Aortography, Contrast Media administration & dosage, Hemodynamics, Iopamidol administration & dosage
- Abstract
Objectives: To evaluate the in vivo feasibility of aortography with one accurately timed diastolic low-volume contrast injection for quantitative assessment of aortic regurgitation (AR) post transcatheter aortic valve replacement (TAVR)., Background: With the rise of a minimalistic approach for TAVR, aortography (re)emerges as a pragmatic tool for AR assessment. In a mock circulation system, we have validated the accuracy of a single diastolic injection triggered by electrocardiogram (ECG) with low-contrast volume., Methods: Two-phase experiment: first, a series of aortograms were performed in a porcine model, with 8 mL of contrast using the synchronized (SYNC) and the conventional non-synchronized (NS) injections. In a second phase, we developed a model of AR by inserting partially unsheathed Wallstents of 6-10 mm of diameter across the pig's aortic valve, performing SYNC injections with 8 mL of contrast and NS injections with 8 mL and 15 mL (rate: 20 mL/sec). Respective accuracies of SYNC vs. NS were assessed using Passing-Bablock regression. An angiography core laboratory performed quantitative AR assessment with videodensitometry (VD-AR)., Results: The SYNC injections produced higher opacification of the aortic root compared with NS injections (P = 0.04 for density). In the second phase, a regression line for predicting VD-AR based on the SYNC injection resulted in a lower intercept and a slope closer to the line of identity (y = 11.9 + 0.79x, P < 0.001, r
2 = 0.94) with the NS-8 mL than with the NS-15 mL injection (y = 26.5 + 0.55x, P < 0.001, r2 = 0.81)., Conclusion: Synchronized diastolic injection with low contrast volume produced denser images in the aortic root and more accurate than the conventional injection; thus, may be an appealing alternative for assessment of AR post TAVR., (© 2018 Wiley Periodicals, Inc.)- Published
- 2019
- Full Text
- View/download PDF
6. Quantitative Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement With Videodensitometry in a Large, Real-World Study Population: Subanalysis of RESPOND and Echocardiogram Association.
- Author
-
Modolo R, Serruys PW, Chang CC, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Onuma Y, Soliman O, and van Mieghem N
- Subjects
- Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Insufficiency diagnostic imaging, Aortic Valve Insufficiency physiopathology, Echocardiography, Heart Valve Prosthesis, Humans, Predictive Value of Tests, Severity of Illness Index, Treatment Outcome, Aortic Valve surgery, Aortic Valve Insufficiency surgery, Aortography methods, Densitometry, Transcatheter Aortic Valve Replacement adverse effects, Transcatheter Aortic Valve Replacement instrumentation
- Published
- 2019
- Full Text
- View/download PDF
7. Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
- Author
-
Abdelghani M, de Winter RJ, Miyazaki Y, Modolo R, Tateishi H, Cavalcante R, Sarmento-Leite R, Mangione JA, Abizaid A, Soliman OII, Onuma Y, Lemos PA, Serruys PW, and de Brito FS Jr
- Subjects
- Aged, Aged, 80 and over, Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency physiopathology, Aortic Valve Stenosis physiopathology, Brazil, Female, Humans, Male, Prosthesis Design, Recovery of Function, Registries, Risk Factors, Severity of Illness Index, Time Factors, Transcatheter Aortic Valve Replacement adverse effects, Treatment Outcome, Aortic Valve surgery, Aortic Valve Insufficiency prevention & control, Aortic Valve Stenosis surgery, Balloon Valvuloplasty adverse effects, Heart Valve Prosthesis, Hemodynamics, Transcatheter Aortic Valve Replacement instrumentation
- Abstract
Objectives: To explore the rate, the determinants of success, and the hemodynamic impact of balloon postdilatation (BPD) of self-expanding transcatheter heart valves (SE-THVs) BACKGROUND: BPD is commonly used to optimize valve expansion and reduce paravalvular leakage (PVL) after transcatheter aortic valve implantation (TAVI) without clearly knowing its hemodynamic benefits., Methods: Patients (n = 307) who received a SE-THV were stratified according to whether a BPD was performed or not. Patients who received BPD were stratified according to the severity of PVL remaining after BPD into two groups: Successful BPD (≤mild PVL + BPD) and Failed BPD (moderate-severe PVL + BPD)., Results: BPD was performed in 121 patients (39.4%) and was successful in 106 patients (87.6% of attempts). A ratio of the postdilatation balloon diameter to the annulus diameter ≤0.95 was an independent predictor of BPD failure (OR: 10.72 [2.02-56.76], P = .005). Peak transvalvular pressure gradient (PG) was lower in the Successful BPD group (14[12-22] mm Hg) than in the Failed BPD group (18[16-23] mm Hg, P = .029), and did not rise in either group during follow-up (median [IQR], 364[161-739] days)., Conclusion: BPD was performed in 39% of patients who received a SE-THV, and was successful in the majority of attempts. BPD failure was more likely in patients with a small postdilatation balloon-to-annulus diameter ratio. Effective BPD improved THV hemodynamic performance, and this was maintained in the intermediate-term post-TAVI., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
8. A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging.
- Author
-
Abdel-Wahab M, Abdelghani M, Miyazaki Y, Holy EW, Merten C, Zachow D, Tonino P, Rutten MCM, van de Vosse FN, Morel MA, Onuma Y, Serruys PW, Richardt G, and Soliman OI
- Subjects
- Aged, Aged, 80 and over, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Densitometry, Female, Heart Valve Prosthesis, Humans, Male, Mitral Valve physiopathology, Mitral Valve Insufficiency etiology, Mitral Valve Insufficiency physiopathology, Observer Variation, Predictive Value of Tests, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Risk Factors, Severity of Illness Index, Transcatheter Aortic Valve Replacement instrumentation, Treatment Outcome, Aortic Valve surgery, Aortography methods, Magnetic Resonance Imaging, Mitral Valve diagnostic imaging, Mitral Valve Insufficiency diagnostic imaging, Transcatheter Aortic Valve Replacement adverse effects
- Abstract
Objectives: This study sought to compare a new quantitative angiographic technique to cardiac magnetic resonance-derived regurgitation fraction (CMR-RF) for the quantification of prosthetic valve regurgitation (PVR) after transcatheter aortic valve replacement (TAVR)., Background: PVR after TAVR is challenging to quantify, especially during the procedure., Methods: Post-replacement aortograms in 135 TAVR recipients were analyzed offline by videodensitometry to measure the ratio of the time-resolved contrast density in the left ventricular outflow tract to that in the aortic root (videodensitometric aortic regurgitation [VD-AR]). CMR was performed within an interval of ≤30 days (11 ± 6 days) after the procedure., Results: The average CMR-RF was 6.7 ± 7.0% whereas the average VD-AR was 7.0 ± 7.0%. The correlation between VD-AR and CMR-RF was substantial (r = 0.78, p < 0.001). On receiver-operating characteristic curves, a VD-AR ≥10% corresponded to >mild PVR as defined by CMR-RF (area under the curve: 0.94; p < 0.001; sensitivity 100%, specificity 83%), whereas a VD-AR ≥25% corresponded to moderate-to-severe PVR (area under the curve: 0.99; p = 0.004; sensitivity 100%, specificity 98%). Intraobserver reproducibility was excellent for both techniques (for CMR-RF, intraclass correlation coefficient: 0.91, p < 0.001; for VD-AR intraclass correlation coefficient: 0.93, p < 0.001). The difference on rerating was -0.04 ± 7.9% for CMR-RF and -0.40 ± 6.8% for VD-AR., Conclusions: The angiographic VD-AR provides a surrogate assessment of PVR severity after TAVR that correlates well with the CMR-RF., (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
9. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.
- Author
-
van Gils L, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Brecker S, Bapat V, Modine T, Soliman OI, Nersesov A, Allocco D, Falk V, and Van Mieghem NM
- Subjects
- Aged, Aged, 80 and over, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Insufficiency diagnostic imaging, Aortic Valve Insufficiency etiology, Arrhythmias, Cardiac diagnosis, Arrhythmias, Cardiac etiology, Arrhythmias, Cardiac therapy, Cardiac Pacing, Artificial, Europe, Female, Humans, Male, Predictive Value of Tests, Product Surveillance, Postmarketing, Prospective Studies, Prosthesis Design, Risk Factors, Transcatheter Aortic Valve Replacement adverse effects, Treatment Outcome, Aortic Valve surgery, Aortography, Contrast Media administration & dosage, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement instrumentation
- Abstract
Objectives: The aim of this post hoc analysis from the RESPOND (Repositionable Lotus Valve System-Post-Market Evaluation of Real World Clinical Outcomes) post-market study was to assess the final implantation depth on the contrast aortogram after Lotus valve (Boston Scientific, Marlborough, Massachusetts) transcatheter aortic valve replacement (TAVR) and to correlate with permanent pacemaker implantation (PPI) and paravalvular leak (PVL)., Background: Contrast aortography allows for the assessment of implantation depth and PVL during and after TAVR. Previous reports suggested an association between final device position and rates of PPI and PVL., Methods: The RESPOND study was a prospective, open-label, single-arm study in 41 centers evaluating outcomes after Lotus TAVR in routine clinical practice. Aortograms were collected at the Erasmus Medical Center and analyzed by researchers who were blinded to clinical outcomes. The primary analysis correlated implantation depth with PPI and PVL and required aortograms in a coaxial projection. The relation between implantation depth and need for PPI was assessed by multivariate logistic regression, adjusting for pre-defined confounders. A secondary analysis compared PVL analysis by contrast aortography with transthoracic echocardiography (TTE) performed by the independent core laboratory., Results: A total of 724 angiographic studies were included in this analysis. Mean Lotus implantation depth was 6.67 ± 2.19 mm. The overall PPI rate was 35%. PPI rate was lower with shallow implants (<6.5 mm: 21% vs. ≥6.5 mm: 41%; p < 0.001). After adjustment for confounders, implantation depth independently predicted need for PPI (odds ratio per 1-mm increment in depth: 1.200; 95% confidence interval: 1.091 to 1.319; p = 0.002). More than trivial PVL was present in 23% by contrast aortography and in 8% by TTE. Implantation depth was not correlated with PVL by contrast aortography or TTE (p = 0.342 and p = 0.149, respectively). PVL grading by contrast aortography and TTE was concordant in 77%., Conclusions: In this post hoc analysis of the RESPOND study PPI was highly correlated with implantation depth, whereas PVL was not. Higher Lotus implantation may reduce need for PPI., (Copyright © 2018. Published by Elsevier Inc.)
- Published
- 2018
- Full Text
- View/download PDF
10. Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation.
- Author
-
Abdelghani M, Miyazaki Y, de Boer ES, Aben JP, van Sloun M, Suchecki T, van 't Veer M, Soliman O, Onuma Y, de Winter R, Tonino PAL, van de Vosse FN, Rutten MCM, and Serruys PW
- Subjects
- Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency physiopathology, Densitometry, Humans, Models, Anatomic, Models, Cardiovascular, Predictive Value of Tests, Prosthesis Design, Severity of Illness Index, Aortic Valve surgery, Aortic Valve Insufficiency diagnostic imaging, Aortography methods, Heart Valve Prosthesis adverse effects, Hemodynamics, Radiographic Image Interpretation, Computer-Assisted methods, Transcatheter Aortic Valve Replacement adverse effects, Transcatheter Aortic Valve Replacement instrumentation
- Abstract
Aims: Videodensitometric assessment of aortography provides a periprocedural quantitation of prosthetic valve regurgitation (PVR) after transcatheter aortic valve implantation. We sought to compare the videodensitometric parameters of PVR severity to the regurgitation fraction (RF) in a controlled in vitro setting., Methods and Results: In a mock circulation system, a transcatheter balloon-expandable valve inserted at the aortic valve position was gradually deformed to induce different grades of paravalvular leakage and the RF was measured with a transonic flow probe. Contrast aortography was performed and the following videodensitometric parameters were generated: left ventricle aortic regurgitation (LV-AR), LV outflow tract AR (LVOT-AR), quantitative regurgitation assessment (qRA) index, relative maximum density (relative max), and maximum upslope of the LV time-density curve. The correlation was substantial between videodensitometric parameters (LV-AR, LVOT-AR, qRA index, relative max, and maximum upslope) and RF (r2=0.96, 0.96, 0.93, 0.87, and 0.93; p<0.001 for all). LV-AR (region of interest [ROI]=entire LV) and LVOT-AR (ROI=LVOT) were not different (p=0.51) and were strongly correlated (r2=0.99) with a mean difference of 1.92% (95% limits of agreement: ±2.83). The correlations of LV-AR and LVOT-AR with RF were stronger when more than one cardiac cycle was included in the analysis (one cycle: r2=0.85 and r2=0.83; four cycles: r2=0.96 and r2=0.96, for LV-AR and LVOT-AR, respectively). Including more cycles beyond four did not improve accuracy., Conclusions: Quantitative assessment of PVR by videodensitometry of aortograms strongly correlates with the actual RF in a controlled in vitro setting. Accuracy is improved by including more than one cardiac cycle in the analysis.
- Published
- 2018
- Full Text
- View/download PDF
11. A novel synchronised diastolic injection method to reduce contrast volume during aortography for aortic regurgitation assessment: in vitro experiment of a transcatheter heart valve model.
- Author
-
Miyazaki Y, Abdelghani M, de Boer ES, Aben JP, van Sloun M, Suchecki T, van 't Veer M, Collet C, Asano T, Katagiri Y, Tenekecioglu E, Soliman OII, Onuma Y, de Winter R, Tonino P, van de Vosse FN, Rutten MCM, and Serruys PW
- Subjects
- Aortic Valve physiopathology, Aortic Valve Insufficiency physiopathology, Diastole, Humans, Injections, Observer Variation, Radiographic Image Interpretation, Computer-Assisted, Reproducibility of Results, Aortic Valve diagnostic imaging, Aortic Valve Insufficiency diagnostic imaging, Aortography methods, Contrast Media administration & dosage, Models, Anatomic, Models, Cardiovascular
- Abstract
Aims: In the minimalist transcatheter aortic valve implantation (TAVI) era, the usage of transoesophageal echocardiography has become restricted. Conversely, aortography has gained clinical ground in quantifying prosthetic valve regurgitation (PVR) during the procedure. In a mock circulation system, we sought to compare the contrast volume required and the accuracy of aortographic videodensitometric PVR assessment using a synchronised diastolic and standard (non-synchronised) injection aortography., Methods and Results: Synchronised diastolic injection triggered by the signal stemming from the mock circulation was compared with standard non-synchronised injection. A transcatheter heart valve was implanted and was deformed step by step by advancing a screw perpendicularly to the cage of the valve in order to create increasing PVR. Quantitative measurement of PVR was derived from time-density curves of both a reference area (aortic root) and a region of interest (left ventricle) developed by a videodensitometric software. The volume of contrast required for the synchronised diastolic injection was significantly less than in the non-synchronised injection (8.1 [7.9-8.5] ml vs. 19.4 [19.2-19.9] ml, p<0.001). The correlation between the two methods was substantial (Spearman's coefficient rho ranging from 0.991 to 0.968). Intraobserver intra-class correlation coefficient for both methods of injection was 0.999 (95% CI: 0.996-1.000) for the synchronised diastolic and 0.999 (95% CI: 0.996-1.000) for the non-synchronised injection group. The mean difference in the rating was 0.17% and limits of agreement were ±1.64% for both groups., Conclusions: A short synchronised diastolic injection enables contrast volume reduction during aortography without compromising the accuracy of the quantitative assessment of PVR using videodensitometry.
- Published
- 2017
- Full Text
- View/download PDF
12. Acute performance of a novel restorative transcatheter aortic valve: preclinical results.
- Author
-
Miyazaki Y, Soliman OII, Abdelghani M, Katsikis A, Naz C, Lopes S, Warnack B, Cox M, Onuma Y, and Serruys PW
- Subjects
- Animals, Aortic Valve Insufficiency diagnostic imaging, Echocardiography, Hemodynamics, Regeneration, Sheep, Absorbable Implants, Aortic Valve physiology, Heart Valve Prosthesis, Tissue Scaffolds, Transcatheter Aortic Valve Replacement
- Abstract
Aims: The Xeltis aortic valve leaflets are made from a bioabsorbable supramolecular polymer that guides the tissue to restoring itself. It is mounted on a self-expanding nitinol frame that includes three feelers and a native leaflet clipping mechanism. We sought to investigate the acute valve performance in a preclinical setting., Methods and Results: In 33 sheep, 26 mm Xeltis aortic valves were transapically implanted in a 23 mm native annulus. Aortography (analysable, n=28) and echocardiography (analysable, n=20) images were acquired immediately after implantation of the Xeltis aortic valve to assess the acute device performance. On echocardiography, transvalvular peak pressure gradient (PG) was 7.4 (IQR: 6.0-8.9) mmHg, mean PG was 4.0 (IQR: 3.0-5.0) mmHg, and effective orifice area was 2.2 (IQR: 1.6-2.5) cm2. Trace (n=6), mild (n=2) and no (n=12) transvalvular aortic regurgitation (AR) were seen. Likewise, no paravalvular AR was detected in 7 cases, whereas trace, mild and moderate were seen in 7, 5 and 1 cases, respectively. On quantitative videodensitometric AR (VD-AR) assessment, a median value of 6% (IQR: 1-12%) of AR was seen. Three cases had a VD-AR superior to 17%, which has a prognostic significance. Out of these three cases, two had echocardiographic assessment available, which showed mild and moderate paravalvular regurgitation due to inadequate leaflet clipping., Conclusions: In a transapical ovine model, the novel restorative transcatheter aortic valve with bioabsorbable leaflets demonstrated good haemodynamic performance comparable to commercially available devices. The highly porous polymeric leaflets demonstrated good competence immediately after implantation with no cases having >mild transvalvular AR.
- Published
- 2017
- Full Text
- View/download PDF
13. Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
- Author
-
Abdelghani M, Tateishi H, Miyazaki Y, Cavalcante R, Soliman OII, Tijssen JG, de Winter RJ, Baan J Jr, Onuma Y, Campos CM, Leite RS, Mangione JA, Abizaid A, Lemos PA, de Brito FS Jr, and Serruys PW
- Subjects
- Aged, Aged, 80 and over, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency physiopathology, Area Under Curve, Brazil, Densitometry, Echocardiography, Doppler, Color, Female, Humans, Male, Predictive Value of Tests, ROC Curve, Registries, Reproducibility of Results, Retrospective Studies, Severity of Illness Index, Treatment Outcome, Aortic Valve surgery, Aortic Valve Insufficiency diagnostic imaging, Aortography methods, Transcatheter Aortic Valve Replacement adverse effects
- Abstract
Objectives: We sought to investigate a new angiographic method for aortic regurgitation (AR) severity assessment in the setting of transcatheter aortic valve implantation (TAVI)., Background: AR after TAVI is common but challenging to quantitate, especially in the cath-lab., Methods: In 228 patients, AR was quantitated before and after TAVI by echocardiography and by video-densitometric analysis of aortograms. Contrast time-density curves for the aortic root (the reference region) and the left ventricular outflow tract, LVOT were generated. LVOT-AR was calculated as the area under the curve of the LVOT as a fraction of the area under the curve of the reference region., Results: LVOT-AR was 0.10 ± 0.08, 0.13 ± 0.10 and 0.28 ± 0.14 in none-trace, mild and moderate-severe post-TAVI AR as defined by echocardiography (P < 0.001) and a cutpoint of >0.17 corresponded to moderate-severe AR on echocardiography (area under the curve = 0.84). At follow-up (median, 496 days), patients with LVOT-AR ≤ 0.17 showed a significant reduction of LV mass index (LVMi; 121 [95-148] vs. 140 [112-169] g/m
2 , P = 0.009) and the prevalence of LV hypertrophy (LVH; 64 vs. 88%, P = 0.001) compared to baseline. In patients with LVOT-AR > 0.17, LVMi (149 [121-178] vs. 166 [144-188] g/m2 , P = 0.14) and the prevalence of LVH (74 vs. 87%, P = 0.23) did not show a significant change. Compared to patients with LVOT-AR ≤ 0.17, those with LVOT-AR > 0.17 had an increased 30-day (16.4% vs. 7.1%, P = 0.035) and one year mortality (32.9 vs. 14.2%, log rank P value = 0.001; HR: 2.690 [1.461-4.953], P = 0.001)., Conclusions: LVOT-AR > 0.17 corresponds to greater than mild AR as defined by echocardiography and predicts impaired LV reverse remodeling and increased early and midterm mortality after TAVI. © 2017 Wiley Periodicals, Inc., (© 2017 Wiley Periodicals, Inc.)- Published
- 2017
- Full Text
- View/download PDF
14. A granular approach to improve reproducibility of the echocardiographic assessment of paravalvular regurgitation after TAVI.
- Author
-
Abdelghani M, Ren B, Spitzer E, Tateishi H, Jonker H, Geleijnse ML, Tijssen JG, de Winter RJ, Serruys PW, and Soliman OI
- Subjects
- Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency physiopathology, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis physiopathology, Cardiac Catheterization instrumentation, Cardiac Catheterization methods, Echocardiography, Doppler, Color, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation methods, Humans, Observer Variation, Predictive Value of Tests, Reproducibility of Results, Severity of Illness Index, Treatment Outcome, Algorithms, Aortic Valve diagnostic imaging, Aortic Valve Insufficiency diagnostic imaging, Aortic Valve Stenosis therapy, Cardiac Catheterization adverse effects, Echocardiography, Doppler methods, Heart Valve Prosthesis Implantation adverse effects, Image Interpretation, Computer-Assisted methods
- Abstract
Paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) is challenging to quantitate. Transthoracic echocardiography (TTE) is the main tool used for the assessment of PVL but is modestly reproducible. We sought to develop a reproducible echocardiographic approach to assess PVL in the post-TAVI setting. Four observers independently analyzed eleven parameters of PVL severity in 50 pre-discharge TTE studies performed after TAVI. The parameters included color-Doppler parameters [jet circumferential extent (CE) and planimetered vena contracta area in the short-axis view and jet breadth and qualitative features in the long-axis views], continuous-wave Doppler parameters [jet velocity time integral (VTI) and pressure half time (PHT)], quantitative Doppler parameters (regurgitation volume and fraction and effective regurgitant orifice area), aortic diastolic flow reversal and valve stent eccentricity. Intraclass correlation coefficient (ICC) and coefficient of variation (CV) for numerical parameters and kappa coefficient (κ) for categorical parameters were calculated for inter- and intra-observer comparisons. Inter-observer ICC was highest and CV lowest for CE (0.88 and 0.36), jet origin breadth (0.82 and 0.39), jet qualitative features in long-axis views (0.87 and 0.26), jet VTI (0.87 and 0.04) and PHT (0.73 and 0.10). Similar results were found in intra-observer comparisons. A 2-step granular approach combining the most reproducible parameters was used to grade PVL by the four observers. Inter-observer agreement was achieved in 86 % of cases (κ = 0.79). Combining color Doppler and continuous wave Doppler parameters in a granular algorithm yields excellent reproducibility of PVL assessment by TTE., Competing Interests: All authors have no relevant conflicts of interest to declare.
- Published
- 2016
- Full Text
- View/download PDF
15. Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal.
- Author
-
Abdelghani M, Soliman OI, Schultz C, Vahanian A, and Serruys PW
- Subjects
- Aortic Valve Insufficiency, Aortic Valve Stenosis, Heart Valve Prosthesis, Humans, Transcatheter Aortic Valve Replacement, Aortic Valve
- Abstract
Paravalvular leakage (PVL) is an important complication of transcatheter aortic valve implantation (TAVI). It contributed to the erosion of the clinical benefits of TAVI and confidence of its adoption as a default therapy in low surgical-risk patients. Newer TAVI technologies are provided with effective paravalvular sealing as well as retrieval/reposition mechanisms that are believed to considerably lower the risk of PVL. Meanwhile, developments in timely detection and accurate quantitation of PVL remain lagging behind those technological advances. The Valve Academic Research Consortium-standardized criteria of PVL assessment are based on echocardiography and are, according to experts' opinion, not adequately validated. Peri-procedural diagnosis, based on angiographic, haemodynamic, and/or echocardiographic methods, is so far without standardization of acquisition or interpretation. The aim of this report is to review the strengths and limitations of the current technologies used for PVL adjudication. Understanding this strengths/limitations ratio is important to define an appropriate scheme for detection and quantitation of PVLs both in clinical trials and in routine clinical practice., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
16. Limitations and difficulties of echocardiographic short-axis assessment of paravalvular leakage after corevalve transcatheter aortic valve implantation.
- Author
-
Geleijnse ML, Di Martino LF, Vletter WB, Ren B, Galema TW, Van Mieghem NM, de Jaegere PP, and Soliman OI
- Subjects
- Aortic Valve surgery, Aortic Valve Stenosis diagnosis, Humans, Prosthesis Design, Prosthesis Failure, Risk Factors, Aortic Valve diagnostic imaging, Aortic Valve Stenosis surgery, Echocardiography, Transesophageal methods, Transcatheter Aortic Valve Replacement adverse effects
- Abstract
To make assessment of paravalvular aortic leakage (PVL) after transcatheter aortic valve implantation (TAVI) more uniform the second Valve Academic Research Consortium (VARC) recently updated the echocardiographic criteria for mild, moderate and severe PVL. In the VARC recommendation the assessment of the circumferential extent of PVL in the short-axis view is considered critical. In this paper we will discuss our observational data on the limitations and difficulties of this particular view, that may potentially result in overestimation or underestimation of PVL severity.
- Published
- 2016
- Full Text
- View/download PDF
17. Quantitative Doppler for Estimation of Paravalvular Leakage after Transcatheter Aortic Valve Implantation.
- Author
-
M Di Martino LF, I Soliman OI, Vletter WB, Ren B, de Vries T, Galema TW, Van Mieghem NM, de Jaegere PP, and Geleijnse ML
- Subjects
- Adult, Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency physiopathology, Case-Control Studies, Female, Heart Valve Prosthesis, Humans, Male, Middle Aged, Observer Variation, Predictive Value of Tests, Prosthesis Design, Reproducibility of Results, Risk Factors, Severity of Illness Index, Stroke Volume, Transcatheter Aortic Valve Replacement instrumentation, Treatment Outcome, Ventricular Function, Left, Ventricular Function, Right, Aortic Valve diagnostic imaging, Aortic Valve surgery, Aortic Valve Insufficiency diagnostic imaging, Echocardiography, Doppler, Transcatheter Aortic Valve Replacement adverse effects
- Abstract
Background: The echocardiographic grading of paravalvular aortic leakage (PVL) after transcatheter aortic valve implantation (TAVI) severity is challenging. The study aim was to assess the value of quantitative Doppler echocardiography to monitor PVL severity., Methods: A total of 100 subjects was enrolled in the study, including 65 consecutive patients who had undergone TAVI with a CoreValve prosthesis and without valvular aortic regurgitation, and 35 normal controls. The PVL volume was calculated using the quantitative Doppler method as the difference of left and right ventricular stroke volume (SV). PVL severity was assessed both visually and quantitatively as the circumferential extent on a short-axis view (SAX)., Results: The inter-observer variabilities for SVs in TAVI patients were disappointing: 14 ± 11% for the left ventricular SV and 18 ± 14% for right ventricular SV. The correlation (r2) between the averaged regurgitant PVL volume and circumferential SAX extent of PVL was 0.02 (p = NS). The relationship between PVL volumes and categories, defined quantitatively by the circumferential SAX extent of PVL and qualitatively by visual assessment of severity of PVL were poor. The results improved when only patients with optimal quality images were included but were still statistically non-significant., Conclusions: The relationship between calculated PVL volume in TAVI patients and other estimates of PVL severity was poor, most likely due to intrinsic errors made in the quantitative Doppler method. Therefore, one should be prudent to include the quantitative Doppler method in TAVI patients in clinical trials and clinical decision-making, in particular in patients with reduced image quality.
- Published
- 2016
18. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry.
- Author
-
Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, Soliman OI, Spitzer E, Perin MA, Onuma Y, Serruys PW, Lemos PA, and Brito FS Jr
- Subjects
- Aged, Aged, 80 and over, Algorithms, Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency physiopathology, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis mortality, Aortic Valve Stenosis physiopathology, Area Under Curve, Brazil, Cardiac Catheterization instrumentation, Cardiac Catheterization methods, Cardiac Catheterization mortality, Feasibility Studies, Female, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation methods, Heart Valve Prosthesis Implantation mortality, Humans, Male, Observer Variation, Predictive Value of Tests, ROC Curve, Radiographic Image Interpretation, Computer-Assisted, Registries, Reproducibility of Results, Retrospective Studies, Risk Factors, Treatment Outcome, Aortic Valve diagnostic imaging, Aortic Valve Insufficiency diagnostic imaging, Aortic Valve Stenosis therapy, Aortography methods, Cardiac Catheterization adverse effects, Densitometry, Heart Valve Prosthesis Implantation adverse effects
- Abstract
Aims: We sought to examine the feasibility and reproducibility of a new video densitometric (VD) quantification of aortic regurgitation (AR) on aortography, and its long-term clinical impact., Methods and Results: Using dedicated video densitometry software, AR after TAVI was quantified, and inter- and intra-observer reproducibility was investigated in 182 aortograms of the Brazilian TAVI registry. The aortograms were analysed using two software algorithms: 1) the quantitative regurgitation analysis (qRA) index interrogating the entire left ventricle (LV), and 2) a new method with the left ventricle outflow tract (LVOT) as a region of interest (ROI) (LVOT-AR). LVOT-AR was feasible in 64.8% vs. 29.7% of aortograms, compared with qRA index. Using the LVOT-AR, inter-observer variability was low (mean difference±standard deviation [SD]: 0.01±0.05, p=0.53), and the two observers' measurements were highly correlated (r=0.95, p<0.001). Patients with LVOT-AR >0.17 had a significantly higher one-year all-cause mortality risk compared with patients with LVOT-AR ≤0.17 (37.1% vs. 11.2%, p=0.0008)., Conclusions: This study proposes an alternative methodology for AR assessment after TAVI by using the LVOT method (LVOT-AR) of VD angiography. The assessment of LVOT-AR is feasible, reproducible and potentially predictive of one-year mortality.
- Published
- 2016
- Full Text
- View/download PDF
19. Prediction of paravalvular leakage after transcatheter aortic valve implantation.
- Author
-
Di Martino LF, Vletter WB, Ren B, Schultz C, Van Mieghem NM, Soliman OI, Di Biase M, de Jaegere PP, and Geleijnse ML
- Subjects
- Aged, Aged, 80 and over, Aortic Valve Insufficiency diagnosis, Aortic Valve Insufficiency physiopathology, Aortic Valve Stenosis diagnosis, Aortic Valve Stenosis physiopathology, Cardiac Catheterization adverse effects, Cardiac Catheterization methods, Echocardiography, Doppler, Color, Female, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation methods, Humans, Linear Models, Male, Multivariate Analysis, Observer Variation, Predictive Value of Tests, Prosthesis Design, Reproducibility of Results, Risk Assessment, Risk Factors, Severity of Illness Index, Tomography, X-Ray Computed, Treatment Outcome, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Aortic Valve Insufficiency etiology, Aortic Valve Stenosis therapy, Cardiac Catheterization instrumentation, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation instrumentation, Prosthesis Failure
- Abstract
Significant paravalvular leakage (PVL) after transcatheter aortic valve implantation (TAVI) is related to patient mortality. Predicting the development of PVL has focused on computed tomography (CT) derived variables but literature targeting CoreValve devices is limited, controversial, and did not make use of standardized echocardiographic methods. The study included 164 consecutive patients with severe aortic stenosis that underwent TAVI with a Medtronic CoreValve system©, with available pre-TAVI CT and pre-discharge transthoracic echocardiography. The predictive value for significant PVL of the CT-derived Agatston score, aortic annulus size and eccentricity, and "cover index" was assessed, according to both echocardiographic Valve Academic Research Consortium (VARC) criteria and angiographic Sellers criteria. Univariate predictors for more than mild PVL were the maximal diameter of the aortic annulus size (for both angiographic and echocardiographic assessment of PVL), cover index (for echocardiographic assessment of PVL only), and Agatston score (for both angiographic and echocardiographic assessment of PVL). The aortic annulus eccentricity index was not predicting PVL. At multivariate analysis, Agatston score was the only independent predictor for both angiographic and echocardiographic assessment of PVL. Agatston score is the only independent predictor of PVL regardless of the used imaging technique for the definition of PVL.
- Published
- 2015
- Full Text
- View/download PDF
20. Transcatheter aortic valve update 2013.
- Author
-
Bourantas CV, Van Mieghem NM, Soliman O, Campos CA, Iqbal J, and Serruys PW
- Subjects
- Cardiac Catheterization instrumentation, Cardiac Catheterization methods, Equipment Design, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation methods, Humans, Prosthesis Failure, Risk Factors, Stroke epidemiology, Treatment Outcome, Aortic Valve, Aortic Valve Stenosis therapy, Cardiac Catheterization trends, Heart Valve Prosthesis Implantation trends
- Abstract
Cumulative evidence has demonstrated that transcatheter aortic valve implantation (TAVI) constitutes an effective treatment option for patients with severe symptomatic aortic stenosis and a high operative risk. New valve designs and TAVI-enabling devices have simplified the procedure, reduced the risk of complications, and broadened the applications of this treatment. The global adoption of TAVI allows us to appreciate the advantages, potentialities and caveats of the technology, identify patients who would benefit from TAVI and stratify more accurately the risk of complications. The focus of this article is to discuss the advances in this field, present the current evidence, and highlight the developments and strategies proposed to address the limitations of TAVI treatment.
- Published
- 2013
- Full Text
- View/download PDF
21. Improved aortic distensibility after aortic homograft root replacement at long-term follow-up.
- Author
-
Nemes A, Galema TW, Soliman OI, Bogers AJ, ten Cate FJ, and Geleijnse ML
- Subjects
- Adult, Aortic Valve Insufficiency pathology, Coronary Artery Bypass, Female, Follow-Up Studies, Heart Valve Prosthesis Implantation, Humans, Male, Middle Aged, Aortic Diseases pathology, Aortic Diseases surgery, Aortic Valve surgery, Aortic Valve Insufficiency surgery, Transplantation, Homologous
- Abstract
Background: The ideal substitute for a diseased aortic valve remains unclear. Usually, the aortic full root replacement (FRR) technique is used, in which the native aortic root is removed and entirely replaced with the homograft aortic root, the coronary arteries being reimplanted into the homograft. The aim of the present study was to examine alterations in aortic size and stiffness in patients after FRR., Methods and Patients: The study comprised 13 patients (mean age 46+/-15 years, 10 males) who underwent FRR because of acute aortic regurgitation due to endocarditis in 6 patients (46%) and aortic valve stenosis with or without regurgitation in 7 patients (54%). These patients underwent transthoracic two-dimensional echocardiography before FRR, before discharge (9+/-8 days post-FRR), and 6 months and 24 months after FRR. Systolic and diastolic ascending aortic diameters were recorded in M-mode at the middle of the ascending aorta, 3 to 4 cm above the aortic valve from a parasternal long-axis view. An aortic stiffness index (beta) was calculated. The results were compared to 13 age-, gender- and risk factor-matched controls., Results: The aortic stiffness index first non-significantly deteriorated from 12.7+/-8.1 to 16.4+/-9.1 immediately after FRR. Subsequently, an improvement to 14.2+/-7.1 (after 6 months) and 7.1+/-4.8 (after 24 months, P<0.05) was seen., Conclusions: FRR is associated with a transient immediate post-FRR deterioration followed by a progressive improvement in aortic distensibility.
- Published
- 2009
- Full Text
- View/download PDF
22. Intraoperative real time three-dimensional transesophageal echocardiographic measurement of hemodynamic, anatomic and functional changes after aortic valve replacement.
- Author
-
Scohy TV, Soliman OI, Lecomte PV, McGhie J, Kappetein AP, Hofland J, and Ten Cate FJ
- Subjects
- Aged, Aortic Valve pathology, Female, Humans, Aortic Valve diagnostic imaging, Echocardiography, Three-Dimensional, Echocardiography, Transesophageal, Heart Valve Prosthesis Implantation adverse effects, Hemodynamics, Intraoperative Complications
- Abstract
The traditional intraoperative two-dimensional transesophageal echocardiography (2DTEE) has limitations in measuring left ventricular ejection fraction (LVEF) because measurements rely on geometric assumptions. The availability of online software and real time three-dimensional transesophageal echocardiography (RT3D-TEE) makes intraoperative LVEF measurements fast and easy. This is the first report of intraoperative measurement of LVEF and aortic valve area (AVA) by RT3-DTEE in a patient who received transcatheter-based transapical aortic valve implantation.
- Published
- 2009
- Full Text
- View/download PDF
23. Aortic distensibility in patients with bicuspid aortic valves.
- Author
-
Nemes A, Soliman OI, Csanády M, and Forster T
- Subjects
- Elasticity, Humans, Aorta physiopathology, Aortic Valve abnormalities
- Published
- 2008
- Full Text
- View/download PDF
24. Predictors of Conduction Disturbances Requiring New Permanent Pacemaker Implantation following Transcatheter Aortic Valve Implantation Using the Evolut Series.
- Author
-
Abdelshafy, Mahmoud, Elkoumy, Ahmed, Elzomor, Hesham, Abdelghani, Mohammad, Campbell, Ruth, Kennedy, Ciara, Kenny Gibson, William, Fezzi, Simone, Nolan, Philip, Wagener, Max, Arsang-Jang, Shahram, Mohamed, Sameh K., Mostafa, Mansour, Shawky, Islam, MacNeill, Briain, McInerney, Angela, Mylotte, Darren, and Soliman, Osama
- Subjects
HEART valve prosthesis implantation ,CARDIAC pacemakers ,MITRAL valve insufficiency ,BUNDLE-branch block ,HEART block ,RECEIVER operating characteristic curves ,AORTIC valve - Abstract
(1) Background: Conduction disturbance requiring a new permanent pacemaker (PPM) after transcatheter aortic valve implantation (TAVI) has traditionally been a common complication. New implantation techniques with self-expanding platforms have reportedly reduced the incidence of PPM. We sought to investigate the predictors of PPM at 30 days after TAVI using Evolut R/PRO/PRO+; (2) Methods: Consecutive patients who underwent TAVI with the Evolut platform between October 2019 and August 2022 at University Hospital Galway, Ireland, were included. Patients who had a prior PPM (n = 10), valve-in-valve procedures (n = 8) or received >1 valve during the index procedure (n = 3) were excluded. Baseline clinical, electrocardiographic (ECG), echocardiographic and multislice computed tomography (MSCT) parameters were analyzed. Pre-TAVI MSCT analysis included membranous septum (MS) length, a semi-quantitative calcification analysis of the aortic valve leaflets, left ventricular outflow tract, and mitral annulus. Furthermore, the implantation depth (ID) was measured from the final aortography. Multivariate binary logistic analysis and receiver operating characteristic (ROC) curve analysis were used to identify independent predictors and the optimal MS and ID cutoff values to predict new PPM requirements, respectively; (3) Results: A total of 129 TAVI patients were included (age = 81.3 ± 5.3 years; 36% female; median EuroSCORE II 3.2 [2.0, 5.4]). Fifteen patients (11.6%) required PPM after 30 days. The patients requiring new PPM at 30 days were more likely to have a lower European System for Cardiac Operative Risk Evaluation II, increased prevalence of right bundle branch block (RBBB) at baseline ECG, have a higher mitral annular calcification severity and have a shorter MS on preprocedural MSCT analysis, and have a ID, as shown on the final aortogram. From the multivariate analysis, pre-TAVI RBBB, MS length, and ID were shown to be predictors of new PPM. An MS length of <2.85 mm (AUC = 0.85, 95%CI: (0.77, 0.93)) and ID of >3.99 mm (area under the curve (AUC) = 0.79, (95% confidence interval (CI): (0.68, 0.90)) were found to be the optimal cut-offs for predicting new PPM requirements; (4) Conclusions: Membranous septum length and implantation depth were found to be independent predictors of new PPM post-TAVI with the Evolut platform. Patient-specific implantation depth could be used to mitigate the requirement for new PPM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis—A Multicentre Real-World Experience.
- Author
-
Elkoumy, Ahmed, Jose, John, Terkelsen, Christian Juhl, Nissen, Henrik, Gunasekaran, Sengottuvelu, Abdelshafy, Mahmoud, Seth, Ashok, Elzomor, Hesham, Kumar, Sreenivas, Bedogni, Francesco, Ielasi, Alfonso, Arsang-Jang, Shahram, Dora, Santosh Kumar, Chandra, Sharad, Parikh, Keyur, Unic, Daniel, Baumbach, Andreas, Serruys, Patrick, and Soliman, Osama
- Subjects
AORTIC stenosis ,MITRAL valve ,HEART valve prosthesis implantation ,CARDIAC pacemakers ,AORTIC valve transplantation ,AORTIC valve ,HEART valves - Abstract
Background: Bicuspid aortic valve (BAV) affects approximately 1.5% of the general population and is seen in nearly 50% of candidates for aortic valve replacement (AVR). Despite increasingly utilised transcatheter aortic valve implantation (TAVI) in aortic stenosis (AS) patients, its use among patients with severe bicuspid AS is limited as BAV is a heterogeneous disease associated with multiple and complex anatomical challenges. Aim: To investigate the one-year outcomes of TAVI using the balloon-expandable Myval transcatheter heart valve (THV) (Meril Life Sciences Pvt. Ltd., Vapi, India) in patients with severe bicuspid AS. Methods and results: We collected data from consecutive patients with bicuspid AS who underwent TAVI with the Myval THV and had at least one-year follow-up. Baseline characteristics, procedural, and 30-day echocardiographic and clinical outcomes were collected. Sixty-two patients were included in the study. The median age was 72 [66.3, 77.0] years, 45 (72.6%) were males, and the mean STS PROM score was 3.2 ± 2.2%. All TAVI procedures were performed via the transfemoral route. The median follow-up duration was 13.5 [12.2, 18.3] months; all-cause mortality was reported in 7 (11.3%) patients and cardiovascular hospitalisation in 6 (10.6%) patients. All-stroke was reported in 2 (3.2%), permanent pacemaker implantation 5 (8.3%), and myocardial infarction 1 (1.6%) patients. The echocardiographic assessment revealed a mean pressure gradient of 10 [8, 16.5] mmHg, effective orifice area 1.7 [1.4, 1.9] cm
2 , moderate AR in 1 (2%), mild AR in 14 (27%), and none/trace AR in 37 (71%). In total, 1 patient was diagnosed with valve thrombosis (2.1%), Stage II (moderate) haemodynamic deterioration was seen in 3 (6.4%), and stage III (severe) haemodynamic deterioration in 1 (2.1%) patient. Conclusions: TAVI with the Myval THV in selected BAV anatomy is associated with favourable one-year hemodynamic and clinical outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
26. Chronic haemodynamic performance of a biorestorative transcatheter heart valve in an ovine model: Chronic haemodynamic performance of a BTHV
- Author
-
Serruys, Patrick, Kawashima, Hideyuki, Chang, Chun, Modolo, Rodrigo, Wang, Rutao, de Winter, Robbert, Van Hauwermeiren, Hadewych, El-Kurdi, Mohammed, van den Bergh, Wian, Cox, Martijn, Onuma, Yoshinobu, Flameng, William, and Soliman, Osama
- Subjects
Catheters ,Sheep ,Clinical Research ,Echocardiography ,Aortic Valve ,Hemodynamics ,Animals ,Aortography - Abstract
BACKGROUND: The Xeltis biorestorative transcatheter heart valve (BTHV) leaflets are made from an electrospun bioabsorbable supramolecular polycarbonate-urethane and are mounted on a self-expanding nitinol frame. The acute haemodynamic performance of this BTHV was favourable. AIMS: We sought to demonstrate the preclinical feasibility of a novel BTHV by evaluating the haemodynamic performances of five pilot valve designs up to 12 months in a chronic ovine model. METHODS: Five design iterations (A, B, B’, C, and D) of the BTHV were transapically implanted in 46 sheep; chronic data were available in 39 animals. Assessments were performed at implantation, 3, 6, and 12 months including quantitative aortography, echocardiography, and histology. RESULTS: At 12 months, greater than or equal to moderate AR on echocardiography was seen in 0%, 100%, 33.3%, 100%, and 0% in the iterations A, B, B’, C, and D, respectively. Furthermore, transprosthetic mean gradients on echocardiography were 10.0±2.8 mmHg, 19.0±1.0 mmHg, 8.0±1.7 mmHg, 26.8±2.4 mmHg, and 11.2±4.1 mmHg, and effective orifice area was 0.7±0.3 cm2, 1.1±0.3 cm2, 1.5±1.0 cm2, 1.5±0.6 cm2, and 1.0±0.4 cm2 in the iterations A, B, B’, C, and D, respectively. On pathological evaluation, the iteration D demonstrated generally intact leaflets and advanced tissue coverage, while different degrees of structural deterioration were observed in the other design iterations. CONCLUSIONS: Several leaflet material iterations were compared for the potential to demonstrate endogenous tissue restoration in an aortic valve in vivo. The most promising iteration showed intact leaflets and acceptable haemodynamic performance at 12 months, illustrating the potential of the BTHV.
- Published
- 2021
27. Advances in transcatheter mitral and tricuspid therapies.
- Author
-
Overtchouk, Pavel, Piazza, Nicolo, Granada, Juan, Soliman, Osama, Prendergast, Bernard, and Modine, Thomas
- Subjects
MITRAL valve insufficiency ,MITRAL valve ,FRAIL elderly ,AORTIC valve ,OLDER patients - Abstract
Background: While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need. The advent of transcatheter therapies offer new treatment options to often elderly and frail patients at high risk for open surgery. We aimed at providing an updated review of fast-growing domain of transcatheter mitral and tricuspid technology.Main Body: We reviewed the existing literature on mitral and tricuspid transcatheter therapies. Mitraclip is becoming an established therapy for secondary mitral regurgitation in selected patients with disproportionately severe regurgitation associated with moderate left ventricle dysfunction. Evidence is less convincing for primary mitral regurgitation. Transcatheter mitral valve replacement is a promising emerging alternative to transcatheter repair, for secondary as well as primary mitral regurgitation. But further development is needed to improve delivery. Transcatheter tricuspid intervention arrives late after similar technologies have been developed for aortic and mitral valves and is currently at its infancy. This is likely due in part to previously under-recognized impact of tricuspid regurgitation on patient outcomes. Edge-to-edge repair is the most advanced transcatheter solution in development. Data on tricuspid annuloplasty and replacement is limited, and more research is warranted.Conclusion: The future appears bright for transcatheter mitral therapies, albeit their place in clinical practice is yet to be clearly defined. Tricuspid transcatheter therapies might address the unmet need of tricuspid regurgitation treatment. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
28. Prediction of paravalvular leakage after transcatheter aortic valve implantation.
- Author
-
Martino, Luigi, Vletter, Wim, Ren, Ben, Schultz, Carl, Mieghem, Nicolas, Soliman, Osama, Biase, Matteo, Jaegere, Peter, Geleijnse, Marcel, Di Martino, Luigi F M, Vletter, Wim B, Van Mieghem, Nicolas M, Soliman, Osama I I, Di Biase, Matteo, de Jaegere, Peter P, and Geleijnse, Marcel L
- Abstract
Significant paravalvular leakage (PVL) after transcatheter aortic valve implantation (TAVI) is related to patient mortality. Predicting the development of PVL has focused on computed tomography (CT) derived variables but literature targeting CoreValve devices is limited, controversial, and did not make use of standardized echocardiographic methods. The study included 164 consecutive patients with severe aortic stenosis that underwent TAVI with a Medtronic CoreValve system©, with available pre-TAVI CT and pre-discharge transthoracic echocardiography. The predictive value for significant PVL of the CT-derived Agatston score, aortic annulus size and eccentricity, and "cover index" was assessed, according to both echocardiographic Valve Academic Research Consortium (VARC) criteria and angiographic Sellers criteria. Univariate predictors for more than mild PVL were the maximal diameter of the aortic annulus size (for both angiographic and echocardiographic assessment of PVL), cover index (for echocardiographic assessment of PVL only), and Agatston score (for both angiographic and echocardiographic assessment of PVL). The aortic annulus eccentricity index was not predicting PVL. At multivariate analysis, Agatston score was the only independent predictor for both angiographic and echocardiographic assessment of PVL. Agatston score is the only independent predictor of PVL regardless of the used imaging technique for the definition of PVL. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
29. Relation between calcium burden, echocardiographic stent frame eccentricity and paravalvular leakage after corevalve transcatheter aortic valve implantation.
- Author
-
Di Martino, Luigi F. M., Soliman, Osama I. I., van Gils, Lennart, Vletter, Wim B., Van Mieghem, Nicolas M., Ren, Ben, Galema, Tjebbe W., Schultz, Carl, de Jaegere, Peter P. T., Di Biase, Matteo, and Geleijnse, Marcel L.
- Subjects
AORTIC valve ,AORTIC stenosis ,CALCIUM ,STATISTICAL correlation ,ECHOCARDIOGRAPHY ,SURGICAL stents ,DESCRIPTIVE statistics - Abstract
Aims Paravalvular aortic leakage (PVL) after transcatheter aortic valve implantation (TAVI) is a complication with potentially severe consequences. The relation between native aortic root calcium burden, stent frame eccentricity and PVL was not studied before. Methods and results Two-hundred-and-twenty-three consecutive patients with severe aortic stenosis who underwent TAVI with a Medtronic CoreValve System© and who had available pre-discharge transthoracic echocardiography were studied. Echocardiographic stent inflow frame eccentricity was defined as major-minor diameter in a short-axis view>2mm. PVL was scored according to the updated Valve Academic Research Consortium (VARC-2) recommendations. In a subgroup of 162 (73%) patients, the calcium Agatston score was available. Stent frame eccentricity was seen in 77 (35%) of patients. The correlation between the Agatston score and stent frame eccentricity was significant (ρ = 0.241, P = 0.003). Paravalvular leakage was absent in 91 cases (41%), mild in 67 (30%), moderate in 51 (23%), and severe in 14 (6%) cases. The correlation between stent frame eccentricity and PVL severity was significant (ρ = 0.525, P < 0.0001). There was a relation between particular eccentric stent frame shapes and the site of PVL. Conclusion Calcification of the aortic annulus is associated with a subsequent eccentric shape of the CoreValve prosthesis. This eccentric shape results in more PVL, with the localization of PVL related to the shape of stent frame eccentricity. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
30. Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility.
- Author
-
Abdelghani, Mohammad, Hiroki Tateishi, Spitzer, Ernest, Tijssen, Jan G., de Winter, Robbert J., Soliman, Osama I. I., Hahn, Rebecca T., and Serruys, Patrick W.
- Subjects
AORTIC valve ,AORTIC valve insufficiency ,CONFIDENCE intervals ,ECHOCARDIOGRAPHY ,LONGITUDINAL method ,RESEARCH evaluation ,STATISTICS ,LITERATURE reviews ,INTER-observer reliability ,RECEIVER operating characteristic curves ,MANN Whitney U Test ,KRUSKAL-Wallis Test ,INTRACLASS correlation - Abstract
Aims Aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) is often first diagnosed by angiography and then confirmed and followed-up by transthoracic echocardiography (TTE). Consistency between both methods is important for follow-up. We sought to determine inter-technique reproducibility of the assessment of paravalvular AR after TAVI. Methods The study included 165 patients treated with a self-expanding bioprosthesis and had angiography and TTE performed at and results a median interval of 4 days. TTE parameters of AR severity included VARC score (the average AR grade determined by the echocardiographic VARC-II criteria), pressure half time (PHT), regurgitation jet features in long-axis views (LAX score) and colour Doppler (CD) score (= paravalvular AR jet circumferential extent (%) + LAX score). Using receiver-operating characteristics curves, the cut-points that best defined an angiographic >mild AR were identified. On TTE, AR was paravalvular in all cases, multi-jet in 28%, and predominantly (64%) detected in the commissural region between the right and left coronary sinuses. Using VARC-II criteria (combining at least two), TTE agreed with angiographic classification in 53% of cases (k = 0.14). Greater than mild AR could better be defined by one of the following combinations of criteria: (i) LAX score >4.25 and VARC-II score >1.33; (ii) CD score >11.5 and PHT <400 ms. The combination of the CD score with PHT gave the best sum of sensitivity, specificity, positive, and negative predictive values. Conclusions Agreement between angiography and TTE (using the VARC-II criteria) in the grading of post-TAVI AR is modest, and this might have contributed to the inconsistency of data on the rate and fate of paravalvular AR. Inter-technique reproducibility can be improved using a combination of CD and hemodynamic parameters. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
31. TCTAP A-081 Early Results of Myval Transcatheter Aortic Valve in Severe Bicuspid Aortic Stenosis (Procedural and 30-Day Outcome).
- Author
-
Elkoumy, Ahmed, Soliman, Osama, Abdelshafy, Mahmoud, Seth, Ashok, Bedogni, Francesco, Elzomor, Hesham, Kumar, Sreenivas Arramraju, Tespili, Maurizio, Parikh, Keyur, and Serruys, Patrick W.
- Subjects
- *
AORTIC valve , *MITRAL valve , *AORTIC stenosis - Published
- 2022
- Full Text
- View/download PDF
32. Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis—A Multicenter Real-World Experience.
- Author
-
Elkoumy, Ahmed, Jose, John, Terkelsen, Christian J., Nissen, Henrik, Gunasekaran, Sengottuvelu, Abdelshafy, Mahmoud, Seth, Ashok, Elzomor, Hesham, Kumar, Sreenivas, Bedogni, Francesco, Ielasi, Alfonso, Dora, Santosh K., Chandra, Sharad, Parikh, Keyur, Unic, Daniel, Wijns, William, Baumbach, Andreas, Mylotte, Darren, Serruys, Patrick, and Soliman, Osama
- Subjects
HEART valve prosthesis implantation ,AORTIC stenosis ,MITRAL valve ,AORTIC valve insufficiency ,AORTIC valve ,HEART valves - Abstract
Bicuspid aortic valve (BAV) is the most common valvular congenital anomaly and is apparent in nearly 50% of candidates for AV replacement. While transcatheter aortic valve implantation (TAVI) is a recommended treatment for patients with symptomatic severe aortic stenosis (AS) at all surgical risk levels, experience with TAVI in severe bicuspid AS is limited. TAVI in BAV is still a challenge due to its association with multiple and complex anatomical considerations. A retrospective study has been conducted to investigate TAVI's procedural and 30-day outcomes using the Myval transcatheter heart valve (THV) (Meril Life Sciences Pvt. Ltd. Vapi, Gujarat, India) in patients with severe bicuspid AS. Data were collected on 68 patients with severe bicuspid AS who underwent TAVI with the Myval THV. Baseline characteristics, procedural, 30-day echocardiographic and clinical outcomes were collected. The mean age and STS PROM score were 72.6 ± 9.4 and 3.54 ± 2.1. Procedures were performed via the transfemoral route in 98.5%. Major vascular complications (1.5%) and life-threatening bleeding (1.5%) occurred infrequently. No patient had coronary obstruction, second valve implantation or conversion to surgery. On 30-day echocardiography, the mean transvalvular gradient and effective orifice area were 9.8 ± 4.5 mmHg and 1.8 ± 0.4 cm
2 , respectively. None/trace aortic regurgitation occurred in 76.5%, mild AR in 20.5% and moderate AR in 3%. The permanent pacemaker implantation rate was 8.5% and 30-day all-cause death occurred in 3.0% of cases. TAVI with the Myval THV in selected BAV anatomy is associated with favorable short-term hemodynamic and clinical outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
33. Insights into Left Ventricular Function from the Time Course of Regional and Global Rotation by Speckle Tracking Echocardiography.
- Author
-
van Dalen, Bas M., Soliman, Osama I.I., Vletter, Wim B., ten Cate, Folkert J., and Geleijnse, Marcel L.
- Subjects
- *
PARTIAL left ventriculectomy , *ECHOCARDIOGRAPHY , *AORTIC valve , *HEART beat , *MITRAL valve - Abstract
Background: Description and quantification of regional left ventricular (LV) rotation and the time course of LV rotation might provide further insight into LV function. Methods: The study comprised 60 healthy volunteers (age 39 ± 15 years, 31 men) in whom complete global and regional LV rotation could be assessed at both the basal and apical LV level with speckle tracking echocardiography, using QLAB advanced quantification software version 6.0 (Philips, Best, The Netherlands). Results: At the LV basal level, a brief counterclockwise rotation from aortic valve opening until 25% ejection was seen in the anterior segments (anterior, anteroseptal, anterolateral) only. Clockwise rotation in the anterior segments at the basal level was decreased as compared to the posterior segments (inferior, inferoseptal, inferolateral) from 25% ejection until aortic valve closure. At the LV apical level, all segments showed a brief clockwise rotation during the isovolumic contraction phase. Also, at this level there were no differences in regional LV rotation at any other moment during the cardiac cycle. There was a marked de-rotation from the moment of maximal rotation until E-peak at the LV basal level (79 ± 18%) whereas de-rotation during this interval was less pronounced at the LV apical level (55 ± 21%). Only at the LV basal level significant linear relationships were seen between the E/A ratio and de-rotation extent and velocity from mitral valve opening until E-peak (R2= 0.42 and R2= 0.40, respectively, both P < 0.001). Conclusion: In the normal human heart significant regional differences in LV rotation and de-rotation exist. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
34. Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE neo 2 versus ACURATE neo Transcatheter Aortic Valve Implantation.
- Author
-
Rück, Andreas, Kim, Won-Keun, Kawashima, Hideyuki, Abdelshafy, Mahmoud, Elkoumy, Ahmed, Elzomor, Hesham, Wang, Rutao, Meduri, Christopher U., Verouhis, Dinos, Saleh, Nawzad, Onuma, Yoshinobu, Mylotte, Darren, Serruys, Patrick W., and Soliman, Osama
- Subjects
HEART valve prosthesis implantation ,AORTIC valve insufficiency ,HEART valves ,AORTIC valve ,ECHOCARDIOGRAPHY - Abstract
The new-generation ACURATE neo2 system was commercially released in September 2020. In this study, we sought to compare the aortic regurgitation (AR) severity of the ACURATE neo2 versus the ACURATE neo transcatheter heart valve, using quantitative videodensitometric angiography (qAR). This is a retrospective, Corelab analysis of final post-transcatheter aortic valve implantation (TAVI) aortograms of patients treated with the ACURATE neo2 and ACURATE neo systems. The ACURATE neo2 cohort comprised consecutive patients treated between September 2020 and January 2021 at two centers. The ACURATE neo cohort included consecutive patients treated before September 2020. Our primary objective was to compare AR severity on qAR following TAVI with ACURATE neo2 and ACURATE neo. Out of 401 aortograms, 228 (56.9%) were analyzable, with 120 in the ACURATE neo2 cohort, and 108 in the ACURATE neo cohort. The mean AR fraction was 4.4 ± 4.8% in the neo2 cohort, and 9.9 ± 8.2% in the neo cohort (p < 0.001). Furthermore, moderate or severe AR (qAR > 17%) was detected in 2 aortograms (1.7%) in the neo2 cohort and 15 aortograms (13.9%) in the neo cohort (p < 0.001). Quantitative aortography shows a lower rate of moderate or severe paravalvular AR in what is the first European experience of the new-generation, self-expanding ACURATE neo2 when compared to the first-generation ACURATE neo. Moreover, aortographic data need to be correlated and compared to Core Laboratory-adjudicated 30-day echocardiographic data. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. TCTAP A-051 Feasibility and Accuracy of Three-Dimension Aortic Valve Annulus Planimetry on Cardiac CT Angiography: A New Full Automatic Deep Learning Method.
- Author
-
Wu, Xinlei, Jiang, YiQiu, Elkoumy, Ahmed, Wang, Xiaodong, Soliman, Osama, Zhang, Xinmin, Wu, Daozhu, and Wu, Lianpin
- Subjects
- *
AORTIC valve , *DEEP learning , *ANGIOGRAPHY - Published
- 2024
- Full Text
- View/download PDF
36. TCT-446 Feasibility study of a single synchronized diastolic injection with low contrast volume for aortography in a progressive aortic regurgitation porcine model.
- Author
-
Modolo, Rodrigo, Chang, Chun Chin, Miyazaki, Yosuke, Hekkert, Maaike, Suchecki, Todd, Aben, Jean-Paul, Soliman, Osama, Onuma, Yoshinobu, Duncker, Dirk, Serruys, Patrick, and Van Mieghem, Nicolas
- Subjects
- *
AORTIC valve insufficiency , *FEASIBILITY studies , *AORTIC valve - Published
- 2018
- Full Text
- View/download PDF
37. TCT-443 Quantitative assessment of aortic regurgitation in 7 different types of aortic valves after transcatheter aortic valve implantation: a multicenter analysis by an independent core lab not sponsored by the industry.
- Author
-
Serruys, Patrick, Modolo, Rodrigo, Miyazaki, Yosuke, Chang, Chun Chin, Kogame, Norihiro, Piazza, Nicolo, Pighi, Michele, Abdelghani, Mohammad, Abdel-Wahab, Mohamed, Rahhab, Zouhair, Soliman, Osama, Onuma, Yoshinobu, Brito, Fabio, Lemos, Pedro A., and Van Mieghem, Nicolas
- Subjects
- *
AORTIC valve insufficiency , *AORTIC valve - Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.